|
Psychosocial impacts of COVID-19 on oncology workforces: Metro versus regional Australia. |
|
Elizabeth Stephanie Ahern |
Research Funding - Amgen (Inst) |
Patents, Royalties, Other Intellectual Property - U.S. Provisional Application No. 62/775803 |
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb |
|
|
Travel, Accommodations, Expenses - Novartis; Novartis |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
Brett Gordon Maxwell Hughes |
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Eisai; MSD Oncology; Pfizer; Roche; Sanofi/Regeneron |
Research Funding - Amgen (Inst) |
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb |
|
|
Consulting or Advisory Role - Ipsen |
|
Research Funding - Ipsen (Inst); Ipsen (Inst) |
Travel, Accommodations, Expenses - Ipsen; Novartis |
|
|
No Relationships to Disclose |
|
|
Travel, Accommodations, Expenses - Novartis |
|
|
|
Consulting or Advisory Role - Abbvie; AstraZeneca; Merck; Roche |
Speakers' Bureau - AstraZeneca |
Research Funding - Abbvie; Bristol-Myers Squibb |
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb |